S

Summary of the MAMMOTH Trial in R/R Myeloma

By Saurabh Chhabra
December 9, 2022
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute's ASH Highlights

Sat, Feb 11, 2023
12:38
SOHO 2022 Tenth Annual Meeting

SOHO 2022 DEBATE: Bispecific Antibodies vs. CAR-T for R/R MM - Defen…

Feat. S. Usmani
15:54
Paul Richardson

Emerging Strategies in the Management of Relapsed MM

30:59
Houston Methodist Hospital

Overview of Advances in Multiple Myeloma

Feat. S. Ganguly
21:38
Rahul Banerjee

CAR-T Therapy in Myeloma: What's Here and What's Coming So…

06:41
Hamza Hashmi

Idecabtagene Vicleucel vs. Ciltacabtagene Autoleucel: A Sophie'…

21:16
UChicago Medicine

Myeloma 2022: Challenges and Path Forward

Feat. A. Jakubowiak
34:48
Kenneth Anderson

MM Cured in 2030 - What Are the Next Steps?

Feat. K. Anderson
10:09
SOHO 2022 Tenth Annual Meeting

SOHO 2022: Next Questions for MM in the Coming 5-10 Years

Feat. T. Martin
45:43
MedNews Week

Multiple Myeloma in 2022: Developments, Directions, and Disparities

Feat. J. Mikhael
34:28
2022 Community Oncology Conference

Treatment Conundrums in Myeloma

Feat. S. Giralt
33:28
Cleveland Clinic Taussig Cancer Institute

Management of Relapsed/Refractory Multiple Myeloma

Feat. F. Anwer
Shambavi Richard

Updates in Sequencing Treatment for Early Multiple Myeloma Relapse

42:10
Houston Methodist Hospital

Role of Genomics in Multiple Myeloma

Feat. N. Munshi
12:11
SOHO 2022 Tenth Annual Meeting

SOHO 2022 DEBATE: Bispecific Antibodies vs. CAR-T for R/R MM - Pro C…

Feat. T. Martin
20:35
PleXus Communications

Relapsed and Refractory MM: Choosing the Right Treatment

Feat. S. Lonial
10:51
Peter Voorhees

IMS 2022 on Updated Results of a Phase 1, First-in-Human Study of AB…

19:48
Penn Medicine Abramson Cancer Center

New Therapies for Relapsed Myeloma

Feat. D. Vogl
11:43
UCSF School of Medicine

CARTITUDE-1: 2 Years Post-LPI Update on the Phase 1b/2 Study of Cilt…

Feat. T. Martin
19:18
Total Health

Updates to Management of Patients With Multiple Myeloma

Feat. S. Kumar
31:36
Nebraska Oncology Society

ASCO 2022 on Moving Toward a Cure in Myeloma: The Role of MRD Testing

Feat. A. Nooka